Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bangladesh Beximco Starts Drugs Exports to Jordan (Bangladesh)

This article was originally published in PharmAsia News

Executive Summary

Bangladesh's top drug maker, Beximco Pharmaceuticals announced Sept. 30 that it will soon begin exporting medicines to Jordan. So far, Beximco has received approval for four different treatments, with several other applications in the works. Jordan has a pharmaceutical market worth an estimated $315 million that primarily relies on imports. The country also boasts a strong infrastructure, a well-regulated healthcare system, and strong trading partnerships throughout the Middle East. Representatives for Beximco say these factors make the country an ideal entry point for the company into the region's markets. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065671

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel